- Home
- /Tissue transglutaminase Ab panel
Tissue transglutaminase Ab panel
Detects antibodies against tissue transglutaminase, a marker of celiac disease.
Why This Biomarker Matters
Positive results suggest celiac disease, an autoimmune disorder causing intestinal damage. Early diagnosis enables dietary management to prevent serious complications.
Overview
Tissue transglutaminase (tTG) antibodies are markers of celiac disease, an autoimmune disorder triggered by gluten consumption. When people with celiac disease eat gluten (found in wheat, barley, and rye), their immune system produces antibodies against tTG, damaging the small intestine. This antibody panel test typically includes IgA anti-tTG and/or IgG anti-tTG. A positive result suggests celiac disease and should be confirmed with intestinal biopsy. This test is essential for diagnosing celiac disease before it causes complications like nutritional deficiencies, osteoporosis, or increased cancer risk.
Related Health Conditions
Conditions where Tissue transglutaminase Ab panel is commonly tested
Related Health Goals
Treatments & Interventions
Therapies monitored using Tissue transglutaminase Ab panel
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
35681-6Primary35280-731017-746128-535285-6Available Lab Tests
Order tests that measure this biomarker
Find Specialists
Doctors who commonly order this test